Position in ABVX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$5,010,750
New position
Shares Held
45,000
first reported quarter
Ownership
0.052%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alberta Investment Management Corp holds $34,419,872 across 6 Biotechnology names. ABVX ranks #2 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,389,200 | $20,087,832 | |
| 2 | ABVX |
Abivax S.A.
This page
|
45,000 | $5,010,750 | |
| 3 | DAWN |
Day One Biopharmaceuticals, Inc.
|
200,000 | $4,288,000 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
35,000 | $3,403,750 | |
| 5 | SLNO |
Soleno Therapeutics Inc
|
25,000 | $837,000 | |
| 6 | ZURA |
Zura Bio Ltd
|
133,200 | $792,540 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,010,750 | 45,000 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||